Medi Caps

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE442D01010
NSEID:
BSEID: 523144

INR

32.25

-1.4 (-4.16%)

BSENSE

Dec 05

BSE+NSE Vol: 1.78 k

{
  "main_header": {
    "sid": 723558,
    "name": "Medi Caps",
    "stock_name": "Medi Caps",
    "full_name": "Medi Caps Ltd",
    "name_url": "stocks-analysis/medi-caps",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.25",
    "chg": -1.4,
    "chgp": "-4.16%",
    "dir": -1,
    "prev_price": "33.65",
    "mcapval": "40.22 Cr",
    "mcap": "Micro Cap",
    "scripcode": 523144,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE442D01010",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.78 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medi-caps-723558-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Medi Caps falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-medi-caps-fallingrising-3745000",
        "imagepath": "",
        "date": "2025-12-04 00:50:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Underperformance Against Benchmarks</strong></p>\n<p>Medi Caps has been struggling to gain positive momentum relative to the Sensex, India's benchmark index. Over the past week, the stock has declined by 6.85%, significantly underperforming the Sensex's modest fall of 0.59%. The one-month performance further highlights this disparity, with Medi Caps falling 13.64% while the Sensex gained 1.34%. Year-to-date figures reveal a stark contrast: the stock has plummeted 33.66%, whereas the Sensex has risen by 8.92%. Even over a one-year horizon, Medi Caps has lost 39.43% of its value, while the Sensex has appreciated by 5.27%. This persistent underperformance signals ongoing challenges for the company or sector that are not reflected in the broader market's positive trajectory.</p>\n<p><st..."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.31.91 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs3191-amidst-continued-weakness-3744353",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MediCaps_priceRelatedfactors_3744353.png",
        "date": "2025-12-03 13:48:47",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.31.91, marking a significant decline in its stock value over the past year. This development comes amid a backdrop of subdued financial performance and persistent challenges reflected in key metrics."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.32.03 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs3203-amidst-weak-financial-metrics-3741420",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MediCaps_priceRelatedfactors_3741420.png",
        "date": "2025-12-02 10:00:57",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.32.03 today, reflecting ongoing challenges in its financial and market performance. This price level marks a significant point for the stock, which has been underperforming relative to key benchmarks over the past year."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.32.03 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs3203-amidst-weak-financial-metrics-3741417",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MediCaps_priceRelatedfactors_3741417.png",
        "date": "2025-12-02 10:00:55",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.32.03 today, reflecting ongoing challenges in its financial and market performance. This decline comes despite a modest gain over the past two days, underscoring persistent pressures on the stock amid broader market dynamics."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.33.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs332-amidst-continued-downtrend-3735814",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MediCaps_priceRelatedfactors_3735814.png",
        "date": "2025-11-28 15:07:52",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.33.2 today, marking a significant point in its ongoing price decline. The stock has experienced a sustained downward trajectory over the past week, reflecting a series of financial and market challenges."
      },
      {
        "title": "Medi Caps Stock Falls to 52-Week Low of Rs.34.25 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-stock-falls-to-52-week-low-of-rs3425-amidst-continued-underperformance-3733686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MediCaps_priceRelatedfactors_3733686.png",
        "date": "2025-11-27 12:48:34",
        "description": "Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.34.25 today, marking a significant milestone in its recent trading performance. This decline comes amid a backdrop of subdued financial results and persistent challenges reflected in key operational metrics."
      },
      {
        "title": "Why is Medi Caps falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-medi-caps-fallingrising-3708681",
        "imagepath": "",
        "date": "2025-11-17 23:00:41",
        "description": "As of 17-Nov, Medi Caps Ltd's stock price is currently at 37.75, reflecting an increase of 0.25 or 0.67%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Despite this recent uptick, the stock has underperformed in the year-to-date and one-year periods, with declines of 22.56% and 24.06% respectively. Additionally, the stock has outperformed its sector by 0.39% today, although it is trading above its 5-day moving averages but below its longer-term moving averages. Notably, there has been a significant drop in investor participation, with delivery volume falling by 88.92% against the 5-day average, indicating reduced trading interest.\n\nIn the broader market context, Medi Caps' short-term performance over the past week shows a gain of 1.32%, which is slightly below the Sensex's increase of 1.69%. While the stock has seen some positive movement today, its overall year-to-dat..."
      },
      {
        "title": "Medi Caps Q2 FY26: Steep Revenue Decline Triggers Mounting Losses",
        "link": "https://www.marketsmojo.com/news/result-analysis/medi-caps-q2-fy26-steep-revenue-decline-triggers-mounting-losses-3698218",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MediCaps_quaterlyResult_3698218.png",
        "date": "2025-11-13 09:34:15",
        "description": "Medi Caps Ltd., India's second-largest manufacturer of empty hard gelatine capsules, reported a troubling second quarter for FY2026, with net sales plummeting 75.63% year-on-year to ₹2.02 crores and the company sliding deeper into losses with a net loss of ₹1.82 crores. The micro-cap pharmaceutical company, currently valued at ₹48.00 crores, has seen its stock price decline 24.25% over the past year, closing at ₹38.63 on November 13, 2025, reflecting mounting investor concerns about the company's operational viability."
      },
      {
        "title": "How has been the historical performance of Medi Caps?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-medi-caps-3695441",
        "imagepath": "",
        "date": "2025-11-13 00:25:03",
        "description": "Answer:\nThe historical performance of Medi Caps shows a significant decline in net sales and profitability over the years, culminating in losses in the most recent fiscal year.\n\nBreakdown:\nMedi Caps experienced a downward trend in net sales, dropping from 69.87 Cr in Mar'22 to 25.47 Cr in Mar'25. This decline is mirrored in total operating income, which also fell from 69.87 Cr in Mar'22 to 25.47 Cr in Mar'25. The company's total expenditure, excluding depreciation, decreased from 59.92 Cr in Mar'22 to 27.30 Cr in Mar'25, yet this was not sufficient to prevent operating losses, with operating profit (PBDIT) declining from 11.86 Cr in Mar'22 to -1.83 Cr in Mar'25. Profit before tax also turned negative, moving from 10.06 Cr in Mar'22 to -0.84 Cr in Mar'25, and profit after tax followed suit, decreasing from 10.04 Cr in Mar'22 to -0.57 Cr in Mar'25. The company's cash flow from operating activities showed a sl..."
      }
    ],
    "total": 78,
    "sid": "723558",
    "stock_news_url": "https://www.marketsmojo.com/news/medi-caps-723558"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Extract of un-audited standalone and consolidated financial results of the company for the quarter/half year ended 30.09.2025 published in free press English edition and choutha sansar Hindi edition dated 14.11.2025. copy of same is attached.",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter As Well As Half Year Ended On 30Th September 2025 Along With Statement Of Assets And Liabilities Cash Flow Statement And Limited Review Report.",
      "datetime": "12-Nov-2025",
      "details": "Unaudited standalone and consolidated financial result of the company for the quarter/half year ended 30 09.2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 12.11.2025.",
      "datetime": "12-Nov-2025",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors at their meeting held on 12th November 2025 has inter alia considered and approved the following businesses: (1) Un-audited Standalone and Consolidated Financial Results of the Company for the quarter as well as half year ended on 30th September 2025 along with Statement of Assets and Liabilities Cash Flow Statement and Limited Review Report thereon. (2) Other routine businesses with the permission of chair. You are requested to please take on record the same.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medi Caps Ltd has declared <strong>15%</strong> dividend, ex-date: 20 Sep 12",
          "dt": "2012-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medi Caps Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Mar 13",
          "dt": "2013-03-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Medi Caps falling/rising?

2025-12-04 00:50:56

Persistent Underperformance Against Benchmarks

Medi Caps has been struggling to gain positive momentum relative to the Sensex, India's benchmark index. Over the past week, the stock has declined by 6.85%, significantly underperforming the Sensex's modest fall of 0.59%. The one-month performance further highlights this disparity, with Medi Caps falling 13.64% while the Sensex gained 1.34%. Year-to-date figures reveal a stark contrast: the stock has plummeted 33.66%, whereas the Sensex has risen by 8.92%. Even over a one-year horizon, Medi Caps has lost 39.43% of its value, while the Sensex has appreciated by 5.27%. This persistent underperformance signals ongoing challenges for the company or sector that are not reflected in the broader market's positive trajectory.

Medi Caps Stock Falls to 52-Week Low of Rs.31.91 Amidst Continued Underperformance

2025-12-03 13:48:47

Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.31.91, marking a significant decline in its stock value over the past year. This development comes amid a backdrop of subdued financial performance and persistent challenges reflected in key metrics.

Medi Caps Stock Falls to 52-Week Low of Rs.32.03 Amidst Continued Underperformance

2025-12-02 10:00:57

Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.32.03 today, reflecting ongoing challenges in its financial and market performance. This price level marks a significant point for the stock, which has been underperforming relative to key benchmarks over the past year.

Medi Caps Stock Falls to 52-Week Low of Rs.32.03 Amidst Continued Underperformance

2025-12-02 10:00:55

Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.32.03 today, reflecting ongoing challenges in its financial and market performance. This decline comes despite a modest gain over the past two days, underscoring persistent pressures on the stock amid broader market dynamics.

Medi Caps Stock Falls to 52-Week Low of Rs.33.2 Amidst Continued Downtrend

2025-11-28 15:07:52

Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.33.2 today, marking a significant point in its ongoing price decline. The stock has experienced a sustained downward trajectory over the past week, reflecting a series of financial and market challenges.

Medi Caps Stock Falls to 52-Week Low of Rs.34.25 Amidst Continued Underperformance

2025-11-27 12:48:34

Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.34.25 today, marking a significant milestone in its recent trading performance. This decline comes amid a backdrop of subdued financial results and persistent challenges reflected in key operational metrics.

Why is Medi Caps falling/rising?

2025-11-17 23:00:41

As of 17-Nov, Medi Caps Ltd's stock price is currently at 37.75, reflecting an increase of 0.25 or 0.67%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Despite this recent uptick, the stock has underperformed in the year-to-date and one-year periods, with declines of 22.56% and 24.06% respectively. Additionally, the stock has outperformed its sector by 0.39% today, although it is trading above its 5-day moving averages but below its longer-term moving averages. Notably, there has been a significant drop in investor participation, with delivery volume falling by 88.92% against the 5-day average, indicating reduced trading interest. In the broader market context, Medi Caps' short-term performance over the past week shows a gain of 1.32%, which is slightly below the Sensex's increase of 1.69%. While the stock has seen some positive movement today, its overall year-to-dat...

Medi Caps Q2 FY26: Steep Revenue Decline Triggers Mounting Losses

2025-11-13 09:34:15

Medi Caps Ltd., India's second-largest manufacturer of empty hard gelatine capsules, reported a troubling second quarter for FY2026, with net sales plummeting 75.63% year-on-year to ₹2.02 crores and the company sliding deeper into losses with a net loss of ₹1.82 crores. The micro-cap pharmaceutical company, currently valued at ₹48.00 crores, has seen its stock price decline 24.25% over the past year, closing at ₹38.63 on November 13, 2025, reflecting mounting investor concerns about the company's operational viability.

How has been the historical performance of Medi Caps?

2025-11-13 00:25:03

Answer: The historical performance of Medi Caps shows a significant decline in net sales and profitability over the years, culminating in losses in the most recent fiscal year. Breakdown: Medi Caps experienced a downward trend in net sales, dropping from 69.87 Cr in Mar'22 to 25.47 Cr in Mar'25. This decline is mirrored in total operating income, which also fell from 69.87 Cr in Mar'22 to 25.47 Cr in Mar'25. The company's total expenditure, excluding depreciation, decreased from 59.92 Cr in Mar'22 to 27.30 Cr in Mar'25, yet this was not sufficient to prevent operating losses, with operating profit (PBDIT) declining from 11.86 Cr in Mar'22 to -1.83 Cr in Mar'25. Profit before tax also turned negative, moving from 10.06 Cr in Mar'22 to -0.84 Cr in Mar'25, and profit after tax followed suit, decreasing from 10.04 Cr in Mar'22 to -0.57 Cr in Mar'25. The company's cash flow from operating activities showed a sl...

View All News

Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Nov-2025 | Source : BSE

Extract of un-audited standalone and consolidated financial results of the company for the quarter/half year ended 30.09.2025 published in free press English edition and choutha sansar Hindi edition dated 14.11.2025. copy of same is attached.

Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter As Well As Half Year Ended On 30Th September 2025 Along With Statement Of Assets And Liabilities Cash Flow Statement And Limited Review Report.

12-Nov-2025 | Source : BSE

Unaudited standalone and consolidated financial result of the company for the quarter/half year ended 30 09.2025.

Board Meeting Outcome for Outcome Of Board Meeting Held On 12.11.2025.

12-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors at their meeting held on 12th November 2025 has inter alia considered and approved the following businesses: (1) Un-audited Standalone and Consolidated Financial Results of the Company for the quarter as well as half year ended on 30th September 2025 along with Statement of Assets and Liabilities Cash Flow Statement and Limited Review Report thereon. (2) Other routine businesses with the permission of chair. You are requested to please take on record the same.